Disorders of cancer metabolism: The therapeutic potential of cannabinoids

Abnormal energy metabolism, as one of the important hallmarks of cancer, was induced by multiple carcinogenic factors and tumor-specific microenvironments. It comprises aerobic glycolysis, de novo lipid biosynthesis, and glutamine-dependent anaplerosis. Considering that metabolic reprogramming provi...

Full description

Bibliographic Details
Main Authors: Dingya Sun, Xin Li, Shengdan Nie, Jiajia Liu, Shan Wang
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222013828
_version_ 1811187832801198080
author Dingya Sun
Xin Li
Shengdan Nie
Jiajia Liu
Shan Wang
author_facet Dingya Sun
Xin Li
Shengdan Nie
Jiajia Liu
Shan Wang
author_sort Dingya Sun
collection DOAJ
description Abnormal energy metabolism, as one of the important hallmarks of cancer, was induced by multiple carcinogenic factors and tumor-specific microenvironments. It comprises aerobic glycolysis, de novo lipid biosynthesis, and glutamine-dependent anaplerosis. Considering that metabolic reprogramming provides various nutrients for tumor survival and development, it has been considered a potential target for cancer therapy. Cannabinoids have been shown to exhibit a variety of anticancer activities by unclear mechanisms. This paper first reviews the recent progress of related signaling pathways (reactive oxygen species (ROS), AMP-activated protein kinase (AMPK), mitogen-activated protein kinases (MAPK), phosphoinositide 3-kinase (PI3K), hypoxia-inducible factor-1alpha (HIF-1α), and p53) mediating the reprogramming of cancer metabolism (including glucose metabolism, lipid metabolism, and amino acid metabolism). Then we comprehensively explore the latest discoveries and possible mechanisms of the anticancer effects of cannabinoids through the regulation of the above-mentioned related signaling pathways, to provide new targets and insights for cancer prevention and treatment.
first_indexed 2024-04-11T14:10:11Z
format Article
id doaj.art-57cf9eca2a414939862e5ab560f70491
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-11T14:10:11Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-57cf9eca2a414939862e5ab560f704912022-12-22T04:19:45ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-01-01157113993Disorders of cancer metabolism: The therapeutic potential of cannabinoidsDingya Sun0Xin Li1Shengdan Nie2Jiajia Liu3Shan Wang4Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, ChinaHunan key laboratory of the research and development of novel pharmaceutical preparations, Changsha Medical University, Changsha, ChinaOffice of Drug Clinical Trial Organization, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China; Corresponding authors.Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, China; Corresponding authors.Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, China; Corresponding authors.Abnormal energy metabolism, as one of the important hallmarks of cancer, was induced by multiple carcinogenic factors and tumor-specific microenvironments. It comprises aerobic glycolysis, de novo lipid biosynthesis, and glutamine-dependent anaplerosis. Considering that metabolic reprogramming provides various nutrients for tumor survival and development, it has been considered a potential target for cancer therapy. Cannabinoids have been shown to exhibit a variety of anticancer activities by unclear mechanisms. This paper first reviews the recent progress of related signaling pathways (reactive oxygen species (ROS), AMP-activated protein kinase (AMPK), mitogen-activated protein kinases (MAPK), phosphoinositide 3-kinase (PI3K), hypoxia-inducible factor-1alpha (HIF-1α), and p53) mediating the reprogramming of cancer metabolism (including glucose metabolism, lipid metabolism, and amino acid metabolism). Then we comprehensively explore the latest discoveries and possible mechanisms of the anticancer effects of cannabinoids through the regulation of the above-mentioned related signaling pathways, to provide new targets and insights for cancer prevention and treatment.http://www.sciencedirect.com/science/article/pii/S0753332222013828CancerCancer metabolismGlycolysisCannabinoidsMetabolic reprogrammingDrug targets
spellingShingle Dingya Sun
Xin Li
Shengdan Nie
Jiajia Liu
Shan Wang
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Biomedicine & Pharmacotherapy
Cancer
Cancer metabolism
Glycolysis
Cannabinoids
Metabolic reprogramming
Drug targets
title Disorders of cancer metabolism: The therapeutic potential of cannabinoids
title_full Disorders of cancer metabolism: The therapeutic potential of cannabinoids
title_fullStr Disorders of cancer metabolism: The therapeutic potential of cannabinoids
title_full_unstemmed Disorders of cancer metabolism: The therapeutic potential of cannabinoids
title_short Disorders of cancer metabolism: The therapeutic potential of cannabinoids
title_sort disorders of cancer metabolism the therapeutic potential of cannabinoids
topic Cancer
Cancer metabolism
Glycolysis
Cannabinoids
Metabolic reprogramming
Drug targets
url http://www.sciencedirect.com/science/article/pii/S0753332222013828
work_keys_str_mv AT dingyasun disordersofcancermetabolismthetherapeuticpotentialofcannabinoids
AT xinli disordersofcancermetabolismthetherapeuticpotentialofcannabinoids
AT shengdannie disordersofcancermetabolismthetherapeuticpotentialofcannabinoids
AT jiajialiu disordersofcancermetabolismthetherapeuticpotentialofcannabinoids
AT shanwang disordersofcancermetabolismthetherapeuticpotentialofcannabinoids